Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of targeted therapies for solid tumors due to its ability to modulate signaling pathways. Also employed in structure-activity relationship (SAR) studies to optimize antitumor activity and selectivity in quinoline-based drug candidates.

Additionally, it serves as a starting material or intermediate in the laboratory synthesis of other bioactive compounds, owing to its iodine group which enables further reactions, such as cross-coupling, to generate new derivatives with therapeutic potential.

Currently, it is not used in commercial or direct medical applications, remaining in the stage of laboratory studies and testing.